Adiponectin

Reference

Definition

Adiponectin is a protein hormone secreted almost exclusively by adipocytes that enhances insulin sensitivity and fatty-acid oxidation while exerting anti-inflammatory and anti-atherogenic effects. Uniquely among adipokines, its circulating levels fall as fat mass rises [1].

Identities

  • Wikipedia: Adiponectin
  • Wikidata: Q357439
  • DBpedia: http://dbpedia.org/resource/Adiponectin

Also Known As

ACRP30; adipoQ; apM1; GBP28; adipocyte complement-related protein of 30 kDa

Examples and Analogies

Picture fat tissue as a factory and adiponectin its quality-control inspector keeping metabolism orderly — the fatter the factory grows, the fewer inspectors it releases. Low adiponectin tracks with central obesity, type 2 diabetes, and fatty liver.

Usage Scenarios

Adiponectin is mainly a research biomarker; Philippine clinical laboratories rarely measure it. Its physiology nevertheless explains why waist circumference and insulin resistance travel together in patients with metabolic syndrome, and why weight loss improves glucose so quickly.

Strategies

Weight loss, regular aerobic exercise, Mediterranean-style eating, and thiazolidinedione drugs raise adiponectin — a key mechanism behind their glucose-lowering effect. No registered supplement reliably raises it; treat “adiponectin-boosting” claims with skepticism.

Security and Safety Measures

Avoid unregistered pills sold online as adiponectin activators; assay methods vary and none are validated for self-monitoring. Kidney disease distorts levels, complicating interpretation — leave measurement to specialists and research protocols.

Historical Context

Four research groups independently discovered the hormone in 1995–1996; its paradoxical inverse relationship with obesity helped recast adipose tissue as a bona fide endocrine organ [1].

Challenges and Controversies

Whether low adiponectin causes or merely flags metabolic disease remains unsettled, assay standardization limits cross-study comparison, and adiponectin-targeted therapy has yet to reach the clinic.

Related Topic

Metabolic Syndrome is the cluster — central obesity, dysglycemia, dyslipidemia, hypertension — in which adiponectin sits mechanistically [2].

References

  1. Adiponectin
  2. Metabolic syndrome

Twenty Twenty-Five

Designed with WordPress